Home> Regulatory Information

Announcement of NMPA and General Administration of Customs on the Establishment of Changchun Airport as a Drug Import Port

CCFDIE|Updated: 2021-06-15

According to the Drug Administration Law of the People's Republic of China, upon approval of the State Council, NMPA and General Administration of Customs agree to establish Changchun Airport as a drug import port. On June 7, 2021, relevant matters are hereby announced as follows:

I. As of the date of issuance of this Announcement, except for the drugs specified in Article 10 of the Provisions for Drug Importation (hereinafter referred to as the Provisions), other imported drugs (including narcotic drugs and psychotropic drugs) may be imported through Changchun Airport.

II. Jilin Medical Products Administration is added as the port drug regulatory authority, which shall undertake the specific drug import filing at Changchun Airport.

III. Jilin Institute for Drug Control is added as the port drug testing institute. As of the date of issuance of this Announcement, Jilin Institute for Drug Control starts to undertake the drug port testing at Changchun Airport.